Calumet (NASDAQ:CLMT) Surprises With Strong Q2 CY2026

via StockStory
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CLMT Cover Image

Specialty products refiner Calumet (NASDAQ:CLMT) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 40.8% year on year to $1.45 billion. Its adjusted EBITDA was significantly above analysts’ consensus estimates.

Is now the time to buy Calumet? Find out by accessing our full research report, it’s free.

Calumet (CLMT) Q2 CY2026 Highlights:

  • Revenue: $1.45 billion vs analyst estimates of $1.09 billion (40.8% year-on-year growth, 32% beat)
  • EPS (GAAP): -$1.09 vs analyst estimates of -$0.06 (significant miss)
  • Adjusted EBITDA: $175.2 million vs analyst estimates of $98.32 million (12.1% margin, 78.2% beat)
  • Operating Margin: -2.8%, up from -9.8% in the same quarter last year
  • Free Cash Flow was $99.35 million, up from -$92.3 million in the same quarter last year
  • Market Capitalization: $3.65 billion

"Calumet continues to execute against every element of our multi-dimensional strategy," said Todd Borgmann, CEO.

Company Overview

With roots dating back to 1919 and facilities strategically positioned from Louisiana to Montana, Calumet (NASDAQ:CLMT) refines crude oil into specialty products like lubricating oils, solvents, and waxes used in cosmetics, batteries, and industrial applications.

Revenue Growth

Cyclical sectors like Energy often flatter weaker operators during favorable price environments, but a longer-term lens separates those from businesses that can consistently perform across market cycles. Thankfully, Calumet’s 12.7% annualized revenue growth over the last five years was decent. Its growth was slightly above the average energy upstream and integrated energy company and shows its offerings resonate with customers.

Calumet Quarterly Revenue

Even a long stretch in Energy can be shaped by a single commodity cycle, so extending the view to ten years adds another perspective and reveals which companies are built to grow regardless of the pricing regime. Calumet’s annualized revenue growth of 2.1% over the last ten years is below its five-year trend, but we still think the results were respectable.

This quarter, Calumet reported magnificent year-on-year revenue growth of 40.8%, and its $1.45 billion of revenue beat Wall Street’s estimates by 32%.

WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.

This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.

Adjusted EBITDA Margin

Adjusted EBITDA margin strips out accounting distortions tied to depletion and historical drilling spend, providing a clearer view of the cash-generating power of the underlying asset base before financing and reinvestment decisions.

Calumet was profitable over the last five years but held back by its large cost base. Its average EBITDA margin of 6.9% was among the worst in the energy upstream and integrated energy sector.

On the plus side, Calumet’s EBITDA margin rose by 1.8 percentage points over the last year, as its sales growth gave it operating leverage.

Calumet Trailing 12-Month EBITDA Margin

This quarter, Calumet generated an EBITDA margin profit margin of 12.1%, up 4.7 percentage points year on year. This increase was a welcome development and shows it was more efficient. This adjusted EBITDA beat Wall Street’s estimates by 78.2%.

Cash Is King

As mentioned above, adjusted EBITDA ignores capital structure and drilling expenditure decisions. These are two huge aspects of an Energy producer, so in order to understand a comprehensive picture of business quality, an investor needs to account for these. Said differently, adjusted EBITDA margins could be solid but free cash flow is abysmal because decline rates of the asset are extreme and the drilling is expensive. Free cash flow tells you about not only the economics of the production that has happened but how much it costs to stay in business as well (further drilling or extraction).

While Calumet posted positive free cash flow this quarter, the broader story hasn’t been so clean. Calumet’s demanding reinvestments have consumed many resources over the last five years, contributing to an average free cash flow margin of negative 3.8%. This means it lit $3.78 of cash on fire for every $100 in revenue.

While the level of free cash flow margins is important, their consistency matters just as much.

Calumet’s ratio of quarterly free cash flow volatility to WTI crude price volatility over the past five years was 14.4 (lower is better), indicating that its cash generation is far more sensitive to commodity-price swings than most peers. This elevated volatility limits its access to capital in downturns and makes it unlikely to act as a consolidator when weaker competitors come under pressure.

You may be asking why we wait until the free cash flow line to perform this stability analysis versus commodity prices. Why not compare revenue or EBITDA to WTI in the case of Calumet? Because what ultimately matters is not how much revenue or profit you earn when prices are high but how much cash you can generate when prices are low. Free cash flow is the superior metric because it includes everything from hedging prowess to growth and maintenance capex to management behavior during good times and bad.

Calumet Trailing 12-Month Free Cash Flow Margin

Calumet’s free cash flow clocked in at $99.35 million in Q2, equivalent to a 6.9% margin. Its cash flow turned positive after being negative in the same quarter last year, marking a potential inflection point.

Key Takeaways from Calumet’s Q2 Results

We were impressed by how significantly Calumet blew past analysts’ EBITDA expectations this quarter. We were also excited its revenue outperformed Wall Street’s estimates by a wide margin. Overall, we think this was a solid quarter with some key areas of upside. The stock remained flat at $42.18 immediately following the results.

Calumet put up rock-solid earnings, but one quarter doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. When making that decision, it’s important to consider its valuation, business qualities, as well as what has happened in the latest quarter. We cover that in our actionable full research report which you can read here (it’s free).

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article